Retraction:
Retraction: Decreased long intergenic noncoding RNA P7 predicts unfavorable prognosis and promotes tumor proliferation via the modulation of the STAT1-MAPK pathway in hepatocellular carcinoma
Metrics: PDF 304 views | ?
1Beijing 302 Hospital, Beijing, 100039, China
2Chinese PLA General Hospital, Beijing, 100853, China
3State Key Laboratory of Pathogens and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China
Published: January 16, 2024
Copyright: © 2024 Cheng et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been retracted: Multiple images in Figure 3C, which illustrates that LincRNA P7 inhibited the proliferation of HCC cells SMMC7721 and Huh7 with colony-forming assay, were found to be fraudulent duplications of images from a previously published Oncotarget paper [1] Figure 2D, which represents results of colony formation in different HCC cells Huh-6, BEL-7402 and SMMC-7721 transfected with unrelated HULC siRNA. As a result, all authors have agreed to the retraction of this paper from Oncotarget.
REFERENCE
1. Li SP, Xu HX, Yu Y, He JD, Wang Z, Xu YJ, Wang CY, Zhang HM, Zhang RX, Zhang JJ, Yao Z, Shen ZY. LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway. Oncotarget. 2016; 7:42431–46. https://doi.org/10.18632/oncotarget.9883. [PubMed]
Original article: Oncotarget. 2018; 9:36057–36066. DOI: https://doi.org/10.18632/oncotarget.23282
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28366